NCT06561425
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06561425
Title A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma (Atalanta-1)
Acronym Atalanta-1
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Galapagos Cell Therapeutics NV
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | BEL

Facility Status City State Zip Country Details
Tufts Medical Center Boston Massachusetts 02111 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Antwerp University Hospital Edegem 2650 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
CHU De Liège Liège 4000 Belgium Details
Cliniques Universitaires Saint-Luc Woluwe-Saint-Lambert 1200 Belgium Details
Academisch Medisch Centrum Amsterdam 1105 AZ Netherlands Details
Leiden University Medical Center Leiden 2333 ZA Netherlands Details
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) Rotterdam 3015 GD Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field